Gynecomastia and sexual impotence associated with methotrexate treatment.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12180746.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Methotrexate (MTX) is the disease modifying antirheumatic drug most frequently used for rheumatoid and psoriatic arthritis (PsA). Several reports associate sexual dysfunction to MTX use. We describe 2 cases of sexual impotence and gynecomastia in patients with PsA treated with MTX. Although the mechanism underlying MTX induced sexual dysfunction is unknown, the potential consequences should be taken in account in view of the steady increase in the number of patients.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Psoriatic
- Erectile Dysfunction
- Gynecomastia
- Methotrexate